MMP2 and prostate cancer: Consequently, if the association between MMP-2-1306 C/T polymorphism and the risk of prostate cancer was truly effective, researchers ought to explore the association between the polymorphism and the risk of aggressive prostate cancer, which may be a new predicting biomarker for the life-threatening disease.